Clinical Trial Update: European Carto® XP REgistry for Validating Specialized CFAE SOftware

View source ↗

Summary

The European Carto XP Registry study completed and posted results to validate specialized CFAE software for atrial fibrillation mapping.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Carto XP system

Snippet

Sponsor: Biosense Webster EMEA | Conditions: Atrial Fibrillation | Status: COMPLETED | Results posted: 2015-12-16